Why Manufacturing Is the New Competitive Edge in Cell and Gene Therapy

About this episode

The episode discusses the competitive edge of manufacturing in cell and gene therapy with insights from Eytan Abraham.

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO partners, the future of cell and gene therapy manufacturing, and the hard-earned lessons behind building sustainable, high-performance organizations in one of the most complex areas of medicine. Pharma Sessions provides general insights into the pharmaceutical and life science...

People in this episode

Host: Jonathan Kaskey

Guest: Eytan Abraham

Topics covered

• cell therapy
• gene therapy
• pharmaceutical manufacturing
• CDMO partners
• high-performance organizations

Keywords

• cell therapy
• gene therapy
• manufacturing
• CDMO
• pharmaceutical industry

Mentioned in this episode

Organizations: Minaris Advanced Therapies

More episodes of Pharma Sessions

• The Question Behind the Question - Field Training with Jennifer Muszik · June 8, 2026 · 29 min
• Why the Small Details Reveal Everything About Your CDMO Partner with Frank Sorce · May 28, 2026 · 30 min
• Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury · May 21, 2026 · 37 min
• Timothy Smith on AI, Data, and Drug Discovery at Takeda · May 14, 2026 · 33 min
• Lessons on Leading Through Uncertainty in Pharma · May 7, 2026 · 36 min
• Where AI Delivers Real Value in Pharma Today with Emily Lewis · April 30, 2026 · 33 min